ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,894,693 | +150153.2% | 60,514 | 0.0% | 0.01% | +37.5% |
| Q3 2023 | $1,261 | -13.0% | 60,514 | 0.0% | 0.01% | -20.0% |
| Q2 2023 | $1,449 | +27.2% | 60,514 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $1,139 | +12.8% | 60,514 | -4.7% | 0.01% | 0.0% |
| Q4 2022 | $1,010 | -99.9% | 63,470 | -5.5% | 0.01% | 0.0% |
| Q3 2022 | $1,099,000 | +16.2% | 67,147 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $946,000 | -41.8% | 67,147 | 0.0% | 0.01% | -30.0% |
| Q1 2022 | $1,626,000 | +45.6% | 67,147 | +41.5% | 0.01% | +66.7% |
| Q4 2021 | $1,117,000 | -25.9% | 47,457 | -47.7% | 0.01% | -25.0% |
| Q3 2021 | $1,507,000 | -61.0% | 90,757 | -42.7% | 0.01% | -66.7% |
| Q2 2021 | $3,862,000 | +310.0% | 158,357 | +333.6% | 0.02% | +300.0% |
| Q1 2021 | $942,000 | -0.8% | 36,522 | +86.3% | 0.01% | -25.0% |
| Q2 2020 | $950,000 | – | 19,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |